Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis
- 1 June 2004
- journal article
- review article
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 4 (6), 349-357
- https://doi.org/10.1016/s1473-3099(04)01045-x
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioningBlood, 2003
- Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal InfectionsClinical Infectious Diseases, 2003
- Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for managementThe Journal of Heart and Lung Transplantation, 2003
- Invasive fungal infections in hematology: new trendsAnnals of Hematology, 2002
- AspergillusGalactomannan Detection in the Diagnosis of Invasive Aspergillosis in Cancer PatientsJournal of Clinical Oncology, 2002
- Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validationBlood, 2001
- Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective studyCancer, 2001
- Non-culture based diagnostic tests for mycotic infectionsMedical Mycology, 2000
- Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: early predictive value and clinical use in invasive aspergillosisThe Pediatric Infectious Disease Journal, 1996
- Comparison of an enzyme immunoassay and latex agglutination test for detection of galactomannan in the diagnosis of invasive aspergillosisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996